Marshall Strother's Avatar

Marshall Strother

@mcstroth.bsky.social

Urologic Oncologist at Oregon Health and Science University

105 Followers  |  25 Following  |  2 Posts  |  Joined: 20.11.2024  |  1.7905

Latest posts by mcstroth.bsky.social on Bluesky

Post image

Late breaking at #ASCO25:

A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial: nej.md/4mh5RPL

@ascocancer.bsky.social

01.06.2025 12:05 β€” πŸ‘ 50    πŸ” 28    πŸ’¬ 2    πŸ“Œ 5
A graph showing the cumulative incidence of recurrent venous thromboembolism (primary efficacy outcome) among patients who received apixaban at a reduced (2.5 mg) or full (5.0 mg) dose twice daily for 12 months.

A graph showing the cumulative incidence of recurrent venous thromboembolism (primary efficacy outcome) among patients who received apixaban at a reduced (2.5 mg) or full (5.0 mg) dose twice daily for 12 months.

In the API-CAT trial involving patients with active cancer and venous thromboembolism, extended anticoagulation with reduced-dose apixaban was noninferior to full-dose apixaban for preventing recurrent thromboembolic events. Full results: nej.md/41YkRZK

#ACC25 | @accintouch.bsky.social

29.03.2025 14:35 β€” πŸ‘ 18    πŸ” 8    πŸ’¬ 1    πŸ“Œ 1
A visual representation of the uncertain treatment duration for patients with bloodstream infection

A visual representation of the uncertain treatment duration for patients with bloodstream infection

In patients with bloodstream infection, early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. Research findings on treatment duration in hospitalized patients are summarized in a new Quick Take video. youtu.be/V68RQ6XwiKQ

#MedSky #PulmSky #IDSky

22.03.2025 19:58 β€” πŸ‘ 17    πŸ” 3    πŸ’¬ 0    πŸ“Œ 1
The Importance of Precise Scientific Communication: Nonrandomized Trials Should Not Be Described as Phase 3, and Registrational-intent Trials Should Not Be Described as Phase 2 Standardized nomenclature for clinical trials is required so that the terms phase 1 (first-in-human dose-finding trials), phase 2 (trials to determine the safety and efficacy of a drug and the value o...

A brief plea to call a spade a spade (or more specifically, call a phase 1 a phase 1; a phase 2 a phase 2; a phase 3 a phase 3). www.europeanurology.com/article/S030...

21.03.2025 17:29 β€” πŸ‘ 9    πŸ” 5    πŸ’¬ 0    πŸ“Œ 0

Please repost to get the word out! @nkgarg.bsky.social and I are excited to present a personalized feed for academics! It shows posts about papers from accounts you’re following bsky.app/profile/pape...

10.03.2025 15:12 β€” πŸ‘ 162    πŸ” 116    πŸ’¬ 8    πŸ“Œ 13

Looked for sure like hematuria to me... I will truly never run out of new stuff to learn about pee apparently

13.03.2025 23:08 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Abstract
Objective
To compare functional and surgical outcomes of robot-assisted ileal ureter replacement (RAIUR) vs robot-assisted kidney autotransplantation (RAKAT).
Patients and Methods

This was a retrospective analysis of patients who underwent RAIUR or RAKAT for long ureteric strictures at eight European tertiary centres (2017–2024). Primary endpoints were maintenance of estimated glomerular filtration rate (eGFR) and postoperative complications within 30 days of surgery, described using the Clavien–Dindo classification. Secondary outcomes included infections, need for lifelong drainage, stricture persistence, and re-intervention for the stricture during follow-up.
Results

A total of 15 and 39 patients underwent RAIUR and RAKAT, respectively. The patients who underwent RAIUR were older (61 vs 45 years, P = 0.03), with more comorbidities (Charlson Comorbidity Index β‰₯3: 67% vs 28%, P = 0.03) and had a lower baseline eGFR (60 vs 87 mL/min/1.73m2, P = 0.007). The median stricture length was 9.6 cm for RAIUR vs 7 cm for RAKAT. Patients who underwent RAIUR had a shorter surgical time (290 vs 355 min, P = 0.008), whereas those who underwent RAKAT had a shorter hospitalisation (5 vs 8 days, P = 0.001). Overall complications were higher after RAIUR (73% vs 31%, P = 0.01), but Clavien–Dindo Grade β‰₯III complications were similar (13% vs 10%). During follow-up, both groups showed slightly improved renal function, low infection rates (13% for RAIUR vs 10% for RAKAT), low stricture persistence (13% for RAIUR vs 7.7% for RAKAT), and minimal need for drainage or re-intervention. The main limitation was the modest sample size.

Abstract Objective To compare functional and surgical outcomes of robot-assisted ileal ureter replacement (RAIUR) vs robot-assisted kidney autotransplantation (RAKAT). Patients and Methods This was a retrospective analysis of patients who underwent RAIUR or RAKAT for long ureteric strictures at eight European tertiary centres (2017–2024). Primary endpoints were maintenance of estimated glomerular filtration rate (eGFR) and postoperative complications within 30 days of surgery, described using the Clavien–Dindo classification. Secondary outcomes included infections, need for lifelong drainage, stricture persistence, and re-intervention for the stricture during follow-up. Results A total of 15 and 39 patients underwent RAIUR and RAKAT, respectively. The patients who underwent RAIUR were older (61 vs 45 years, P = 0.03), with more comorbidities (Charlson Comorbidity Index β‰₯3: 67% vs 28%, P = 0.03) and had a lower baseline eGFR (60 vs 87 mL/min/1.73m2, P = 0.007). The median stricture length was 9.6 cm for RAIUR vs 7 cm for RAKAT. Patients who underwent RAIUR had a shorter surgical time (290 vs 355 min, P = 0.008), whereas those who underwent RAKAT had a shorter hospitalisation (5 vs 8 days, P = 0.001). Overall complications were higher after RAIUR (73% vs 31%, P = 0.01), but Clavien–Dindo Grade β‰₯III complications were similar (13% vs 10%). During follow-up, both groups showed slightly improved renal function, low infection rates (13% for RAIUR vs 10% for RAKAT), low stricture persistence (13% for RAIUR vs 7.7% for RAKAT), and minimal need for drainage or re-intervention. The main limitation was the modest sample size.

Just published: Robotic ileal ureter replacement vs kidney autotransplantation for long ureteric strictures

bjui.pub/41G1zrH

13.03.2025 08:30 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
The absolute volume of Gleason Pattern 4 on radical prostatectomy is more strongly associated with advanced stage and biochemical recurrence than Gleason grade groups | Journal of Urology Purpose:ISUP Grade-Group (GG) is based on the relative proportion of Gleason patterns 3 and 4. We investigated whether absolute pattern 4 volume is more strongly associated with advanced stage and bio...

Total amount of pattern 4 provides superior prognostic information than grade groups. Further research should investigate the best pattern 4 quantification method. www.auajournals.org/doi/10.1097/...

28.02.2025 13:26 β€” πŸ‘ 5    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

Comparison of Adjuvant regimens for cancer across tumor types #GU25. Nivolumab per Checkmate 274 for #bladdercancer rises to the top. docs.google.com/presentation...

15.02.2025 15:36 β€” πŸ‘ 7    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

My favorite SHIM score is 1,5,5,5,5, which is a man with good erections who interpreted the first question ("How do you rate your confidence that you could get and keep an erection?") to mean RIGHT NOW on command here in my office.

It's a very poorly worded question.

29.01.2025 03:12 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

The clearest sign of intellectual chemistry isn’t agreeing with someone. It’s enjoying your disagreements with them.

Harmony is not the combination of identical sounds. It’s the pleasing arrangement of different tones, voices, or instruments.

Creative tension makes beautiful music.

26.01.2025 18:37 β€” πŸ‘ 1789    πŸ” 234    πŸ’¬ 48    πŸ“Œ 16
Post image Post image Post image

Cancer Statistics 2025 are out! #prostatecancer incidence still on the rise, mortality basically flat. Get screened so you can get treatment _when needed_. #pcsm
acsjournals.onlinelibrary.wiley.com/doi/epdf/10....

16.01.2025 23:25 β€” πŸ‘ 9    πŸ” 4    πŸ’¬ 2    πŸ“Œ 0
Preview
Neurokinin-3 Receptor Antagonism for Refractory Hot Flashes in Men | NEJM A man with prostate cancer who was receiving androgen blockade had a substantial reduction in the frequency of hot flashes with the use of fezolinetant.

A man with prostate cancer who was receiving androgen blockade had a substantial reduction in the frequency of hot flashes with the use of fezolinetant. Read the full correspondence: nej.md/3DNhtbx

#MedSky

15.01.2025 17:01 β€” πŸ‘ 10    πŸ” 2    πŸ’¬ 0    πŸ“Œ 1
Post image Post image Post image

Awesome talk by @joshmeeks.bsky.social on trial design in NMIBC. Huge need to get away from single arm trials. #SUO24

05.12.2024 17:47 β€” πŸ‘ 18    πŸ” 4    πŸ’¬ 1    πŸ“Œ 3

@mcstroth is following 20 prominent accounts